The US Court of Appeals for the Second Circuit reversed a dismissal of a Defend Trade Secrets Act (DTSA) claim at the pleading stage, finding that a plaintiff need not disclose every detail of its trade secret to state a claim. The Court also found that misappropriation does not require exact copying but includes use of proprietary information to accelerate development of a competing product. SS&C Tech. Holdings, Inc. v. Arcesium LLC, Case No. 25-2049 (2d Cir. Nov. 3, 2026) (Sack, Livingston, Carney, JJ.)
SS&C owns Geneva, a portfolio accounting software platform used by financial institutions. In 2015, SS&C’s predecessor entered into an agreement authorizing Arcesium to sublicense Geneva and provide related services to customers. The agreement restricted Arcesium’s use of Geneva’s proprietary information and prohibited its use to develop competing products. While operating under the agreement, Arcesium developed its own competing portfolio accounting platform, Trinity, and a separate interface, Nautilus, that allegedly enabled continued access to Geneva after the license expired. SS&C alleged that Arcesium used Geneva’s proprietary data models, integration layer, and software functionality to develop these products. SS&C also pointed to internal communications discussing Geneva’s functionality, the accelerated development of Trinity, and Arcesium’s representations to customers that Trinity could replicate Geneva’s capabilities.
The district court dismissed SS&C’s misappropriation claims, finding that although SS&C adequately alleged the existence of trade secrets, it failed to plausibly allege that Arcesium misappropriated them. SS&C appealed.
Pleading a trade secret
Arcesium argued that SS&C failed to identify its alleged trade secrets with sufficient specificity, asserting that the complaint described only broad categories of information accessible to licensed users. The Second Circuit rejected that argument, explaining that a complaint need only identify the alleged trade secrets with sufficient detail to provide notice of the basis for the claim and permit the defendant to ascertain their boundaries. SS&C satisfied that standard by identifying Geneva’s executable software, integration layer, application programming interfaces, and data model, and explaining their functions.
The Second Circuit also rejected Arcesium’s argument that providing licensed customers with access to Geneva undermined its trade secret protection. The Court explained that disclosure to third parties does not necessarily destroy trade secret protection when the information is shared subject to confidentiality obligations. SS&C’s licensing restrictions and nondisclosure agreements sufficiently alleged reasonable measures to maintain secrecy.
Misappropriation
The Second Circuit also emphasized that misappropriation is not limited to exact copying. Citing to the US Court of Appeals for the Third Circuit’s decision in Oakwood Laboratories v. Thanoo (2021), the Second Circuit explained that “use” may include exploiting trade secrets to accelerate research and development, improve competing products, or solicit customers.
Applying that interpretation, the Second Circuit found that SS&C plausibly alleged misappropriation through Arcesium’s use of Geneva’s proprietary functionality to develop Trinity and Nautilus. The allegations included Arcesium’s replication of Geneva’s data models and integration layer, reliance on Geneva’s functionality to resolve technical problems, and development of competing software on an accelerated timeline.
The Second Circuit explained that these allegations must be considered collectively rather [...]
Continue Reading
read more


Subscribe

